Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies
Clinical trial NCT02576496 · COMPLETED
Trial details
- NCT number
- NCT02576496
- Sponsor
- Mundipharma Research Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2023-05-30
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.